Offer - Urjas Oil for just ₹ 1 X
Eltroxin 25 Tablet (120) is a commercial drug that is prescribed in the form of Tablet. It is primarily used for the treatment of Hypothyroidism. Other than this, Eltroxin 25 Tablet (120) has some other therapeutic uses, which have been discussed ahead.
Medical history of the patient along with age and gender determines the dosage of Eltroxin 25 Tablet (120). Individual symptoms and route of administration also determines the right dosage. Detailed information has been provided in the dosage section.
Some other side effects of Eltroxin 25 Tablet (120) have been listed ahead. These side effects of Eltroxin 25 Tablet (120) are usually temporary and subside with the completion of treatment. Please speak with your doctor if these side effects worsen or persist for a longer duration.
Eltroxin 25 Tablet (120)'s effect during pregnancy is Safe and Safe while nursing. Further, the section on Eltroxin 25 Tablet (120) related warnings talks about Eltroxin 25 Tablet (120)'s effects on the liver, heart and kidney.
Individuals suffering from medical conditions like Heart Disease must refrain from the use of Eltroxin 25 Tablet (120) since this can cause severe adverse effects. Other contraindications of Eltroxin 25 Tablet (120) have been discussed in the sections ahead.
Drug interactions for Eltroxin 25 Tablet (120) have been reported in the medical literature. See below for a complete list.
In addition to the above precautions for Eltroxin 25 Tablet (120), it is important to know that it is safe while driving, and is habit-forming.
Eltroxin 25 Tablet (120) is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Based on research, the following side effects have been observed when Eltroxin 25 Tablet (120) is used -
Moderate
Mild
Is the use of Eltroxin 25 Tablet (120) safe for pregnant women?
Pregnant women can take Eltroxin safely.
Is the use of Eltroxin 25 Tablet (120) safe during breastfeeding?
Eltroxin is completely safe for breastfeeding women.
What is the effect of Eltroxin 25 Tablet (120) on the Kidneys?
Eltroxin rarely affects the kidneys.
What is the effect of Eltroxin 25 Tablet (120) on the Liver?
There may be an adverse effect on the liver after taking Eltroxin. If you observe any side effects on your body then stop taking this drug. Take this medicine again only if your doctor advises you to do so.
What is the effect of Eltroxin 25 Tablet (120) on the Heart?
Eltroxin can cause side effects that could harm the heart. So medical advice before taking it is necessary.
Eltroxin 25 Tablet (120) should not be taken with following medicines due to severe side effects it may cause to patients -
Moderate
Mild
If you are suffering from any of the following diseases, you should not take Eltroxin 25 Tablet (120) unless your doctor advises you to do so -
Is this Eltroxin 25 Tablet (120) habit forming or addictive?
Eltroxin 25 Tablet (120) is not addictive in nature.
Is it safe to drive or operate heavy machinery when consuming?
Eltroxin 25 Tablet (120) does not cause dizziness or sleep, so you can drive a vehicle or operate machinery also.
Is it safe?
Eltroxin 25 Tablet (120) should be used only after doctor's advice.
Is it able to treat mental disorders?
Eltroxin 25 Tablet (120) is unable to treat or cure mental disorders.
Interaction between Food and Eltroxin 25 Tablet (120)
Due to a lack of research, nothing can be said about the consequences of taking Eltroxin 25 Tablet (120) together with food.
Interaction between Alcohol and Eltroxin 25 Tablet (120)
No research has been done on this till date. Therefore, it is not known what the effect of taking Eltroxin 25 Tablet (120) with alcohol will be.
Eltroxin is a brand name of thyroxine and it comes in the form of a tablet. It is a prescription drug which is used for the treatment of diseases that arises due to deficiency of thyroid hormones such as hypothyroidism, pituitary TSH suppression, stupor, Hashimoto's disease, myxedema coma, and goiter.
Eltroxin contains thyroxine which is a synthetic form of naturally occurring thyroid hormone that is produced by the thyroid gland (butterfly gland) in our body. It works by restoring the normal levels of thyroxine in the body whose deficiency is resulting in the disease or disorder. Thyroid hormone helps in the synthesis and regulation of certain hormones (adrenaline and dopamine). It also helps in breaking down (Metabolism) the proteins and processing carbohydrates and vitamins which maintains body weight along with growth and development. In this way Eltroxin works in restoring the normal levels of this hormone which our body requires to complete these essential tasks.
Yes, Eltroxin might cause high blood pressure and increased heartbeat as well because it helps in the regulation of certain hormones such as adrenaline in our body which might affect the heartbeat and blood pressure.
No, Eltroxin is a prescription drug so do not use it without consulting a doctor. It can be harmful for the patient to use this medicine without a doctor's recommendation because it can cause unpleasant side effects. Hence, the patient should seek doctors advice before using this medication by himself or herself.
No, Eltroxin does not cause dry mouth. It has not been reported by the patients who are taking this drug. However, if you are experiencing dry mouth after taking this drug then it might be caused by other reason. You are advised to discuss it with your doctor if it persists or becomes severe.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Levo-T® (levothyroxine sodium)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 769-770